Drug Rehab USA: 100-Point Expert Evaluation Rubric

Andrew McKenna - Expert Content Editor

Content Written By:

Andrew McKenna - JD

SUD treatment executive, national news contributor & keynote speaker.

Purpose. This methodology provides a consistent, independent and defensible framework for selecting the Top 10 drug and alcohol rehabilitation programs in each state. It evaluates what matters when a person enters treatment: clinical competence, safety, individualized care, dignity, family involvement, a realistic recovery plan and support that does not end at discharge. Advertising relationships, brand size and luxury amenities do not determine rank.

Minimum eligibility and regulatory gate

  • Verify the current state license or certification for the exact legal entity, physical address and services represented.
  • Verify any claimed ASAM level of care and independent accreditation. Accreditation strengthens the score but does not replace state authorization or site-level due diligence.
  • Review available licensing actions, final orders, corrective-action plans, patient-safety findings, complaints and ownership information before scoring.
  • Exclude a facility when serious unresolved safety, ethical, regulatory or deceptive-marketing concerns make a numerical score misleading.

The final score reflects the combined evaluation of all 14 categories. Greater weight is placed on licensing, clinical quality, evidence-based treatment, patient safety, individualized care, co-occurring mental health treatment, and continuity of recovery support than on amenities or reputation alone.

Our 100-point evaluation system is designed to assess addiction treatment centers based on factors that directly affect clinical quality, patient safety, dignity, continuity of care, and long-term recovery. Rather than rewarding luxury amenities or marketing claims, the evaluation focuses on measurable standards that can help distinguish high-quality treatment programs.

Facilities are evaluated for current site-level licensing and authorization, including whether they are appropriately approved to provide the specific services and ASAM levels they advertise. Accreditation, regulatory history, complaints, enforcement actions, and relevant patient-safety concerns are also considered.

High-quality treatment should be individualized rather than based on a one-size-fits-all approach. This category evaluates assessment and treatment planning, medical and psychiatric oversight, ongoing reassessment, measurable treatment goals, and documented flexibility when clinically appropriate.

Programs should also demonstrate that patients have a meaningful voice in their care and that treatment plans can be adjusted as their needs, circumstances, and recovery goals change.

Treatment centers are evaluated on their appropriate use of evidence-supported approaches to addiction and mental health care. These may include cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing, medications for addiction treatment, trauma-focused interventions, and other clinically supported practices.

Effective addiction treatment often requires different levels of care at different stages of recovery. Facilities are evaluated on their ability to provide or effectively coordinate appropriate services such as withdrawal management, residential treatment, partial hospitalization programs (PHP), intensive outpatient programs (IOP), outpatient treatment, and medication services.

Particular attention is given to how effectively patients transition between levels of care.

Substance use disorders frequently occur alongside mental health conditions. Programs receive credit for providing integrated assessment and treatment of both substance use and mental health needs using appropriately trained and credentialed professionals.

Quality treatment should provide an environment in which patients are treated with dignity and respect. This includes organization-wide trauma-informed practices, appropriate privacy, meaningful patient choice, respectful limit-setting, grievance protections, and safeguards against humiliation, intimidation, or coercion.

The evaluation considers not only formal policies but also how those principles are reflected in everyday patient care.

Families and other approved support systems can play an important role in recovery. A meaningful family program should go beyond visitation or occasional educational sessions.

Facilities are evaluated on whether they provide structured family education, counseling or therapy, participation in treatment planning when appropriate, discharge preparation, and resources that help family members understand addiction, recovery, boundaries, and their own support needs.

Recovery does not end when a patient leaves treatment. Strong programs provide closed-loop transitions into the next stage of care and maintain meaningful connections with patients over time.

This may include proactive follow-up, recovery coaching, scheduled check-ins, alumni programs, peer support, re-engagement services, and assistance returning to treatment when additional care becomes necessary.

The qualifications and availability of treatment professionals are essential to safe and effective care. This category considers the credentials, experience, supervision, staffing availability, and continuing education of medical, clinical, nursing, peer-support, and other treatment staff.

The physical treatment environment should support health and recovery. Facilities are evaluated for clean and safe living areas, nutritious and reasonably palatable meals, access to hygiene resources, appropriate opportunities for sleep and privacy, recreation, and timely attention to maintenance or repair concerns.

Luxury itself does not increase clinical quality. High-end mattresses, entertainment systems, elaborate recreational amenities, and similar features may improve comfort, but they should not substitute for effective treatment and patient care.

Treatment should help patients develop practical knowledge and skills they can use after discharge.

Programs may receive credit for life-skills education, overdose prevention, naloxone education and access, recognition of wounds and other health concerns, appropriate medical referrals, communicable-disease education and testing linkages, tobacco and nicotine support, and other interventions that improve everyday health and safety.

The emphasis is on whether patients leave treatment with usable knowledge, resources, and connections—not simply whether a topic appears in a curriculum.

Treatment providers should clearly and accurately represent who they are and what they offer. Evaluation includes transparency regarding ownership and contact information, accurate descriptions of services, ethical advertising and marketing practices, realistic treatment claims, and the absence of patient brokering, improper inducements, or material misrepresentation.

Patient experience is considered using patterns found across credible sources, complaints, feedback, and facility responses. Recurring themes are given greater weight than individual reviews or isolated ratings.

Online reputation is therefore considered as one component of the evaluation rather than being treated as a direct measure of clinical quality.

Treatment must also be reasonably accessible to the people who need it. This category considers admissions availability, insurance and payment options, transportation, accommodations, physical accessibility, and the facility’s ability to appropriately serve specialized populations.

Automatic disqualification or presumptive exclusion

  • Invalid, suspended or inappropriate licensing for the services or location represented.
  • Serious recent regulatory, patient-safety, sanitation, abuse, neglect or exploitation findings that remain unresolved.
  • Credible evidence of deceptive marketing, misrepresented accreditation, credentials, outcomes, locations or services.
  • Credible evidence of patient brokering, improper inducements, abandonment, retaliation or other serious unethical conduct.
  • A pattern of humiliating, coercive or privacy-violating treatment inconsistent with client rights and trauma-informed care.
  • Inability to independently verify that the facility provides the treatment services it advertises.
  • Blanket interference with or refusal to facilitate clinically appropriate medications for addiction treatment without a defensible clinical and legal basis.

Evidence and ranking principles

  • Clinical quality comes first. Amenities, scenery and luxury accommodations do not substitute for treatment.
  • Do not rank based on advertising relationships, paid listings, SEO visibility or brand size.
  • Use caution with success rates. Give more weight to transparent definitions, denominators, follow-up periods, retention, patient-reported outcomes and independent validation.
  • Distinguish written policy from observed practice. Verify high-value claims through chart audit, schedule review, patient feedback, inspection records and staff interviews when available.
  • Document the rationale for every selected program, major point award, major deduction and exclusion.
  • Disclose any financial, referral, employment, consulting or personal relationship with a program under review. Use an independent second reviewer for any affected score or rank.